(Q43715615)

26 November 2017

title

Improved LC methods for the determination of diosmin and/or hesperidin in plant extracts and pharmaceutical formulations (English)

1 reference

(2S)-5-hydroxy-2-(3-hydroxy-4-methoxyphenyl)-7-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-[[(2R,3R,4S,5R,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxymethyl]oxan-2-yl]oxy-2,3-dihydrochromen-4-one

26 November 2017

1 reference

1 reference

1 reference

1 reference

1 reference

El-Shafae AM

1

1 reference

26 November 2017

El-Domiaty MM

series ordinal

2

1 reference

26 November 2017

publication date

1 November 2001

1 reference

Journal of Pharmaceutical and Biomedical Analysis

26 November 2017

published in

1 reference

26 November 2017

volume

26

1 reference

26 November 2017

issue

4

1 reference

26 November 2017

page(s)

539-545

1 reference

Neutrophil activation and mediators of inflammation in chronic venous insufficiency

26 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0731-7085%2801%2900476-9

7 January 2021

Protective effect of diosmetin on in vitro cell membrane damage and oxidative stress in cultured rat hepatocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0731-7085%2801%2900476-9

7 January 2021

Chemopreventive effects of diosmin and hesperidin on N-butyl-N-(4-hydroxybutyl)nitrosamine-induced urinary-bladder carcinogenesis in male ICR mice

1 reference

https://api.crossref.org/works/10.1016%2FS0731-7085%2801%2900476-9

7 January 2021

Chemoprevention of azoxymethane-induced rat colon carcinogenesis by the naturally occurring flavonoids, diosmin and hesperidin.

1 reference

https://api.crossref.org/works/10.1016%2FS0731-7085%2801%2900476-9

7 January 2021

10.1016/S0731-7085(01)00476-9

Identifiers

DOI

1 reference

26 November 2017

1 reference